UeberCyclamen europaeum

Report of two cases of Mycobacterium europaeum from Iran.

Herein, we report repeated isolation of Mycobacterium europaeum from the sputum samples of an Iranian human immunodeficiency virus-infected patient and a cystic fibrosis patient with chronic pulmonary disease. To our knowledge, this is the first isolation of M. europaeum from human clinical specimens in Asia to be reported.

Draft Genome Sequence of Mycobacterium europaeum Strain CSUR P1344

We report the draft genome sequence of Mycobacterium europaeum strain CSUR P1344, a slowly growing mycobacterium of the Mycobacterium simiae complex and opportunistic respiratory tract colonizer and pathogen. This genome of 6,152,523 bp exhibits a 68.18% G+C content, encoding 5,814 predicted proteins and 74 RNAs.

Pharmacoeconomics of Cyclamen europaeum in the management of acute rhinosinusitis.

OBJECTIVES/HYPOTHESIS To carry out a pharmacoeconomic analysis of Cyclamen europaeum (CE) in the management of acute rhinosinusitis (ARS) in Spain using data from the PROSINUS (PROspective epidemiological study of the diagnosis and treatment of acute rhinoSINUSitis) study. STUDY DESIGN This was a prospective observational study to compare the effectiveness and cost-effectiveness between thera...

Pharmacoeconomics of Cyclamen europaeum (Nasodren®/Sinuforte®) in the management of Acute Rhinosinusitis

Mycobacterium europaeum sp. nov., a scotochromogenic species related to the Mycobacterium simiae complex.

Four strains isolated in the last 15 years were revealed to be identical in their 16S rRNA gene sequences to MCRO19, the sequence of which was deposited in GenBank in 1995. In a polyphasic analysis including phenotypic and genotypic features, the five strains (including MCRO19), which had been isolated in four European countries, turned out to represent a unique taxonomic entity. They are scoto...